Evidence-Based Medicine Guidelines
Low-molecular-weight-heparins compared to unfractionated heparin in ST-segment elevation myocardial infarction treated with thrombolysis
Low-molecular-weight-heparins compared to unfractionated heparin in ST-segment elevation myocardial infarction treated with thrombolysis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Low-molecular-weight-heparins Compared to Unfractionated Heparin in ST-segment Elevation Myocardial Infarction Treated With Thrombolysis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451777/all/Low_molecular_weight_heparins_compared_to_unfractionated_heparin_in_ST_segment_elevation_myocardial_infarction_treated_with_thrombolysis.
Low-molecular-weight-heparins compared to unfractionated heparin in ST-segment elevation myocardial infarction treated with thrombolysis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451777/all/Low_molecular_weight_heparins_compared_to_unfractionated_heparin_in_ST_segment_elevation_myocardial_infarction_treated_with_thrombolysis. Accessed May 20, 2022.
Low-molecular-weight-heparins compared to unfractionated heparin in ST-segment elevation myocardial infarction treated with thrombolysis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451777/all/Low_molecular_weight_heparins_compared_to_unfractionated_heparin_in_ST_segment_elevation_myocardial_infarction_treated_with_thrombolysis
Low-molecular-weight-heparins Compared to Unfractionated Heparin in ST-segment Elevation Myocardial Infarction Treated With Thrombolysis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2022 May 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451777/all/Low_molecular_weight_heparins_compared_to_unfractionated_heparin_in_ST_segment_elevation_myocardial_infarction_treated_with_thrombolysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Low-molecular-weight-heparins compared to unfractionated heparin in ST-segment elevation myocardial infarction treated with thrombolysis
ID - 451777
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451777/all/Low_molecular_weight_heparins_compared_to_unfractionated_heparin_in_ST_segment_elevation_myocardial_infarction_treated_with_thrombolysis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
